Leerink Partners upgraded Align Technology Inc ALGN, citing upside opportunities throughout 2025 given gross margin expansion opportunities.Align Technology — a medical device company that manufactures and sells dental aligners, scanners, and software for digital orthodontics and restorative dentistry — will benefit from improving consumer sentiment, easing comps and continued equipment traction with Lumina.In October, Align Technology announced that it is planning to repurchase $275 million of its common s ...

Company Performance - Shares of Align Technology (NASDAQ: ALGN), the market leader in clear aligners, have fallen more than 20% over the past year due to slowing growth in a tough macroeconomic environment where discretionary spending by consumers has been impacted [1] Analyst Background - The analyst is an individual investor with a focus on undercovered companies, particularly in technology, software, electronics, and the energy transition sectors [1] - The analyst has over 7 years of personal investing experience and a Masters degree in Electrical Engineering, currently working as an automotive battery R&D engineer in Sweden [1] - The analyst enjoys researching small to mid-cap companies that are often less covered by others, aiming to identify asymmetric investment opportunities for market-beating returns [1]

Align Technologies’ (ALGN) robust potential for Invisalign is well-poised to help it grow in the coming quarters. The company’s slew of strategic expansions also looks encouraging. Also, iTero is gaining from the rapidly evolving intraoral scanning technology in the industry. Meanwhile, the macroeconomic volatilities remain a concern for Align Technologies’ operations, while adverse currency impacts may limit its revenues.In the past year, this Zacks Rank #3 (Hold) stock has declined 22.5% against the 1.7% ...

Align Technology's (ALGN) dental procedures continue to be affected by the current economic uncertainty. The competitive landscape also remains an overhang. The stock carries a Zacks Rank #4 (Sell) currently.Factors Dragging ALGN Shares DownThe ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting revenues and margins for Align Technology. Deteriorating international trade, with global inflationary pressure leading to a tough situation related to raw material and labo ...

It has been about a month since the last earnings report for Align Technology (ALGN) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Align Technology due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Align Technology's Q3 Earnings Top Es ...

Align Technologies (ALGN) has received a CE Mark in Europe under the Medical Device Regulation (MDR 2017/745) for its Invisalign Palatal Expander System. The system has completed registration with MHRA for the United Kingdom and overseas territories.The latest developments mark a milestone in the company’s efforts to enhance clinical outcomes and efficiency in orthodontics. Both approvals are for broad patient applicability, including growing children, teens and adults (with surgery or other techniques).ALG ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________ FORM 10-Q ____________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | |----------------------------------------------------------------|------- ...

Align Technology, Inc. (ALGN) recently announced the release of the next version of Invisalign Smile Architect software. The software now supports Multiple Treatment Plans, which is likely to allow doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side. The Multiple Treatment Plans are integrated into ClinCheck treatment planning software which allows doctors to visually compare, review, and choose the best treatment option for each patient. Likely Trend o ...

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial. Align Technology (NASDAQ: ALGN ) recently reported mixed Q3 earnings with a beat on EPS, but a slight miss on revenue. A glance at the headline numbers shows that the company's non-GAAP EPS came in at $2.35, which beat the Street's estimate by $0.04. Me ...

Align Technology, Inc. (ALGN) delivered third-quarter 2024 adjusted earnings per share (EPS) of $2.35, up 9.8% from the year-ago level. The reported figure topped the Zacks Consensus Estimate by 1.7%.GAAP EPS for the quarter was $1.55, reflecting a decline of 1.9% from $1.58 in the comparable period of 2023. Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, ALGN stock plunged 1.49% yesterday.ALGN’s Q3 RevenuesThe top line increased 1.8% year over yea ...